Weiwei Hu

PLAGL2‐EGFR‐HIF‐1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity

Weiwei Hu, Shufang Zheng, Haixin Guo et al. · Hepatology · 2020 · 90 citations

Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance

Weiwei Hu, Lei Fang, Wuyang Hua et al. · Journal of Inorganic Biochemistry · 2017 · 70 citations

Cisplatin Resistance, Tumor Biology, Drug Targeting +10

Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer

Weiwei Hu, Po‐Chun Chen, Junming Chen et al. · Oncotarget · 2017 · 58 citations · Full text

A CK2-targeted Pt(IV) prodrug to disrupt DNA damage response

Feihong Chen, Xiaochao Huang, Mian Wu et al. · Cancer Letters · 2016 · 51 citations

Pharmacology, Novel Therapy, Ck2-targeted Pt

Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families

Jie‐Mei Gu, Wenjin Xiao, Jin‐Wei He et al. · Acta Pharmacologica Sinica · 2009 · 43 citations · Full text

Obesity, Genetics, Esr1 Gene Polymorphisms +7